Mindray Discloses New Products - Analyst Blog
16 Gennaio 2012 - 2:45PM
Zacks
Mindray Medical
International Limited (MR), a leading Chinese medical
device manufacturer, recently provided an update on its new product
launches during 2011 and its pipeline for both the Chinese and
overseas markets for 2012.
During the past year, Mindray
launched 7 new products, such as A5 and A3 anesthesia machines and
the BeneHeart D3 defibrillator, in its patient monitoring and life
support line of business.
The company commercialized the
BC-6800 five-part hematology analyzer and some reagents for its
in-vitro diagnostic product line. It launched 5 offerings,
including the DC-8 color ultrasound system, in its medical imaging
product line.
Mindray plans to launch 7 to 10 new
products for 2012. The company will maintain a balance between the
high-end and low-end market segments. During 2012, Mindray has
decided to grow its product offerings in patient monitoring and
life support areas, such as anesthesia delivery and complete IT
solutions for ICUs. The company also has plans for growth in
in-vitro diagnostics as well as medical imaging.
Mindray is a bellwether in the
Chinese MedTech industry with a solid international presence. A key
distinction with domestic competitors is that the majority of
Mindray’s products have CE Mark and/or Food and Drug Administration
(“FDA”) clearance.
The company has entered the premium
segment globally, where its competitive advantage is still unclear.
Also, on the negative side, health care reform, in China and the
U.S., may reduce demand for Mindray’s products. Competition is
fierce and leads to price erosion over time.
Mindray’s competitors, in different
niche segments, include General Electric (GE),
Philips (PHG) and Siemens (SI).
Our Neutral recommendation on Mindray is supported by a short-term
Zacks #3 Rank (Hold).
GENL ELECTRIC (GE): Free Stock Analysis Report
MINDRAY MEDICAL (MR): Free Stock Analysis Report
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
SIEMENS AG-ADR (SI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024